Drugs for Treatment of Bone Diseases
Drugs for Treatment of Bone Diseases Companies (2)
Drugs for Treatment of Bone Diseases Products (8)
-
Product Synthetic Peptide APIs Portfolio
US DMF Approved: • Vasopressin • Icatibant acetate • Leuprolide acetate • Linaclotide • Etelcalcetide • Desmopressin US DMF Filed: • Calcitonin salmon • Ganirelix acetate • Degarelix • Glatiramer acetate • Plecanatide • Teriparat... -
Product 0.6 ) Calcium & Vitamin D3 Tablets
Application: - · Used as Dietary supplement · Supports bone health · Revives normal calcium levels in body Therapeutic Indication: - · Indicated for Hypocalcemia · Improves muscle strength and bone density -
Product Calciobase
Calciobase is a calcium-based food supplement with sweetener, which provides calcium in its bioactive form calcium-citrate. Calciobase is useful to anyone who needs to integrate shortage of dietary calcium caused by eating habits, lifestyle, or other factors influencing the calcium homoestasis. Calciobase ... -
Product BoniM Tablet/ Injection (Ibandronate 150mg/3mg)
Well-proven efficacy & safety High Improved Quality of Life Monthly, BoniM Tab.150mg Quarterly, BoniM Inj. 3mg
Boni M Injection (Ibandronate 3mg) Indication: Treatment of postmenopausal osteoporosis Administration/Dosage: 3mg every 3 months administered intravenously over a period of 15 to 30 seco... -
Product Duloxeprin
Active ingredient : Duloxetne
Dosage Form :
1 - 2 Capsules Once Daily
Indication :
Centrally actng analgesic for:- Peripheral Diabetc neuropathic pain.
- Chronic low back pain.
- Fibromyalgia.
- Chronic pain in Osteoarthrits. -
Product SINOGEL
Treatment of pain or reduced mobility due to degenerative affections (arthrosis),post-traumatic affections and tendinopathies associated with joint disability. -
Product 0.9 ) Glucosamine & Chondroitin Tablets
Application: - · Helps with good bone health · Improves cushioning between joints · Provides anti-inflammatory effects Therapeutic Indication: - · Indicated to slow down deterioration of cartilage · Used in conditions of Osteoarthritis · Reduces bone degradation -
Product SINOVIAL HL
Pain or reduced mobility due to degenerative diseases (arthrosis), post-traumaticdiseases and tendinopathy associated with joint disabilities.
Upcoming Events
-
CPHI Middle East 2024
Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
10 Dec 2024 - 12 Dec 2024 -
Pharmapack Europe 2025
Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
22 Jan 2025 - 23 Jan 2025 -
CPHI Japan 2025
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
09 Apr 2025 – 11 Apr 2025
Pharmaceutical Industry Webinars
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance